Small molecule inhibitors, such as BI‐69A11, can inhibit all three isoforms of AKT and suppress the cell viability of melanoma with NRAS mutation in vitro and the growth of xenografts tumor models [235, 236]. The gene discussed is AKT1; the disease is neoplasm.